1. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Issue 10278 (13th March 2021) Authors: Wouters, Olivier J; Shadlen, Kenneth C; Salcher-Konrad, Maximilian; Pollard, Andrew J; Larson, Heidi J; Teerawattananon, Yot; Jit, Mark Journal: Lancet Issue: Volume 397:Issue 10278(2021) Page Start: 1023 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. High drug prices are not justified by industry's spending on research and development. (15th February 2023) Authors: Angelis, Aris; Polyakov, Roman; Wouters, Olivier J; Torreele, Els; McKee, Martin Journal: BMJ Issue: Volume 380(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. QALYs in cost-effectiveness analysis: an overview for cardiologists. Issue 23 (22nd September 2015) Authors: Wouters, Olivier J; Naci, Huseyin; Samani, Nilesh J Journal: Heart Issue: Volume 101:Issue 23(2015) Page Start: 1868 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Rethinking the appraisal and approval of drugs for type 2 diabetes. (9th October 2015) Authors: Naci, Huseyin; Lehman, Richard; Wouters, Olivier J; Goldacre, Ben; Yudkin, John S Journal: BMJ Issue: Volume 351(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Risks to health and the NHS in the post-Brexit era. (16th June 2020) Authors: van Schalkwyk, May C I; Jarman, Holly; Hervey, Tamara; Wouters, Olivier J; Barlow, Pepita; McKee, Martin Journal: BMJ Issue: Volume 369(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗